Paper169261
Interaction of a chick skin collagen fragment (alpha1-CB5) with human platelets. Biochemical studies during the aggregation and release reaction.
Chiang TM and 2 others. J Biol Chem, 1975. Cited by 99 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Interaction of a chick skin collagen fragment (alpha1-CB5) with human platelets. Biochemical studies during the aggregation and release reaction. Papers, record 169261. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/169261
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Blood Platelets | Major topic |
| Collagen | Major topic |
| Platelet Aggregation | Major topic |
| Animals | |
| Chickens | |
| Cyclic AMP | |
| Cyclic GMP | |
| Epinephrine | |
| Humans | |
| Kinetics | |
| L-Lactate Dehydrogenase | |
| Peptide Fragments | |
| Serotonin | |
| Skin |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 99 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 9,329,973 | A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation. | J Clin Invest | 1997 | https://conductscience.org/library/papers/9329973 | PubMed |
| 6,097,226 | Cyclic AMP inhibition of fMet-Leu-Phe-dependent metabolic responses in human neutrophils is not due to its effects on cytosolic Ca2+. | Biochem J | 1984 | https://conductscience.org/library/papers/6097226 | PubMed |
| 2,863,286 | N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. | J Clin Invest | 1985 | https://conductscience.org/library/papers/2863286 | PubMed |
| 2,539,100 | Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites. | Biochem J | 1989 | https://conductscience.org/library/papers/2539100 | PubMed |
| 1,311,555 | Inhibition of human platelet adenylate cyclase by collagen fibres. Effect of collagen is additive with that of adrenaline, but interactive with that of thrombin. | Biochem J | 1992 | https://conductscience.org/library/papers/1311555 | PubMed |
| 838,857 | Binding of collagen alpha1 chains to human platelets. | J Clin Invest | 1977 | https://conductscience.org/library/papers/838857 | PubMed |
| 557,500 | Platelet interaction with modified articular cartilage. Its possible relevance to joint repair. | J Clin Invest | 1977 | https://conductscience.org/library/papers/557500 | PubMed |
| 324,916 | Interaction of lipoteichoic acid of group A streptococci with human platelets. | Infect Immun | 1977 | https://conductscience.org/library/papers/324916 | PubMed |
| 198,432 | Collagen-mediated platelet aggregation. Evidence for multivalent interactions of intermediate specificity between collagen and platelets. | J Clin Invest | 1977 | https://conductscience.org/library/papers/198432 | PubMed |
| 29,607 | Factors affecting the activity of guanylate cyclase in lysates of human blood platelets. | Biochem J | 1978 | https://conductscience.org/library/papers/29607 | PubMed |
| 20,630 | Stimulation of human platelet guanylate cyclase by unsaturated fatty acid peroxides. | Proc Natl Acad Sci U S A | 1977 | https://conductscience.org/library/papers/20630 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/169261
GET https://conductscience.org/api/papers/v1/169261/authors